Interestingly, CEMK-9 X NahG and TRI-2 X NahG F 1 plants showed an intermediate HR phenotype similar to that in wild type tobacco and TMV titers correlated well with the extent of HR-type necrosis ( Figure 3 )
M., Zhang, S., Yang, A., Huang, Y., Dawson, T
Investment Strategy: Biologics LOE For institutional investors, the analytical question at a biologic LOE is not how much will biosimilars capture but rather: (1) what is the net price convergence trajectory between the reference product and biosimilar competitors under real-world formulary conditions, (2) does the innovator have pre-negotiated rebate contracts that lock in formulary position for 12 to 24 months post-launch, (3) what is the IP stack on the successor asset, and (4) how far along is the clinical conversion to a reformulated or combination version that carries fresh exclusivity
ALCAR is an esterified form of L-carnitine with an acetyl group attached to its molecular structure
